Company news

Actinogen Medical Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Successful Capital Raising to Support Alzheimers Research

February 10, 2016

Shareholder Update

February 10, 2016

Rights issue prospectus (with amended timetable)

February 10, 2016

Rights Issue Prospectus

February 10, 2016

Rights issue closure and notice of remaining shortfall

February 10, 2016

Response to Price Query Letter

February 10, 2016

Response to ASX query

February 10, 2016

Response to ASX Appendix 4C Query

February 10, 2016

Response to ASX Appendix 4C query

February 10, 2016

Response to Appendix 4C ASX Query

February 10, 2016

Resonse to ASX Query - Price Query

February 10, 2016

Range of Patented Biodegradable Nappies etc to be developed

February 10, 2016

R&D Tax Rebate Received

February 10, 2016

Preliminary Final Report - Appendix 4E

February 10, 2016

Preliminary Final Report

February 10, 2016

Positive Trial Results for Alzheimers Drug Xanamem

February 10, 2016

Placement, Appendix 3B & Section 708A Notice

February 10, 2016

Non-Renounceable Rights Issue and Prospectus

February 10, 2016

New patent application for biofumigation process

February 10, 2016

New Discovery of Making Shikimic Acid

February 10, 2016

New Discovery for Plant Growth in Wheat, Peas and Broad Bean

February 10, 2016

New Biodegradable Shopping Bags and many other products

February 10, 2016

Market Update and Clarification

February 10, 2016

Independent trials being conducted on Plant Growth Hormones

February 10, 2016

Further Clinical Trial Update on Xanamem

February 10, 2016

First Participants Recruited for 2nd Phase 1 Xanamem Study

February 10, 2016

Excellent Research Progress with Promising Alzheimers Drug

February 10, 2016

EU Patent Granted-Further Extends Xanamem Protection

February 10, 2016

Ethics Approval Granted for Second Phase 1 Study of Xanamem

February 10, 2016

Ethics Approval Granted for 2nd Stage of Phase 1 Study

February 10, 2016

Discovery of New Method to produce Anacardic Acid

February 10, 2016

Closure of laboratory

February 10, 2016

Clinical Trial Update-Xanamem Drug for Alzheimers Dementia

February 10, 2016

Clinical Trial Successfully Completed with Xanamem

February 10, 2016

Capital Raising

February 10, 2016

Biofuel program update

February 10, 2016

Bio-ethanol Commercialisation Strategy

February 10, 2016

Appendix 4D Half Yearly Report and Accounts

February 10, 2016

Appendix 4D and Half Yearly Accounts

February 10, 2016

Appendix 4D and Half Year Accounts

February 10, 2016

Appendix 4C

February 10, 2016

ACW: LER to Fund 1st Trial on Actingoen's Bioethanol Project

February 10, 2016

Activity Report & Appendix 4C

February 10, 2016

Actinogen to receive further funding from Otsana Capital

February 10, 2016

Actinogen to acquire Corticrine Limited

February 10, 2016

Actinogen scales up Anacardic Acid production

February 10, 2016

Actinogen New Discovery in the Biofuel Research Program

February 10, 2016

Actinogen Medical Appoints Dr Bill Ketelbey as CEO

February 10, 2016

Actinogen Isolates Demonstrate Antitumorigenic Activity

February 10, 2016

Actinogen Board Changes

February 10, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 88 decks. Every deck is listed under its year.